Zantac and Ranitidine

What is Zantac?

Ranitidine, known commonly by the brand name Zantac, is a popular heartburn treatment. The drug decreases stomach acid production. It was initially available as prescription only in the 1970s but has been available as a generic drug for decades. By 2017 it was still the 48th-most-often prescribed drug in America.

Why Are Zantac and Ranitidine Being Recalled?

The FDA’s recall announcement follows 2019 research finding N-Nitrosodimethylamine (NDMA), a probable human carcinogen, in ranitidine. FDA testing confirmed the 2019 discovery of NDMA in some ranitidine products. NDMA contamination increases both over time and when the product is stored at higher than room temperatures.

In the recall notice, the FDA said that testing and evaluation showed NDMA in ranitidine increased even under normal storage conditions. The older the product is (the longer since it was manufactured) the greater the level of probable carcinogen NDMA.

A lab in California petitioned the FDA (pdf link) to remove all ranitidine products from the market. Their testing found that after being stored for only 5 days above 70 degrees Celsius (158 degrees Fahrenheit) the level of NDMA had risen above the FDA limit.

Injuries Associated with Zantac

The NDMA that can develop within stored Zantac or ranitidine is classified as a probable human carcinogen. That means it probably causes cancer in humans. Studies have shown it is a powerful carcinogen in animal tests. The CDC guidance on NDMA (pdf link) says that in animal studies “after being given by mouth, NDMA enters the bloodstream and goes to many organs of the body in a matter of minutes.”

What Can You Do?

Consumers are advised to stop taking any OTC Zantac or ranitidine in their possession and to speak with their medical providers about alternate treatment opinions. You should retain any unused medication if you believe you may have a legal claim.

Trust Our Massachusetts Zantac Lawyers To Help

Attorney Marilyn McGoldrick of Thornton Law Firm LLP is actively investigating cases on behalf of individuals who took Zantac or ranitidine equivalent products and were thereafter diagnosed with cancer. If you were diagnosed with cancer while using ranitidine or Zantac, you may have a legal claim for damages. Contact Attorney McGoldrick online or at 1-888-341-1405 for a free consultation with a recognized leader in Massachusetts drug and medical device litigation. You have nothing to risk. We offer a fair and accurate assessment of your case.

Contact Us